Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced outside the brain (salivary ionocytes) | 0.10 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 7 Parkinson's papers of 3,635 | 0.73 |
| pathways Reactome | 2 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 9635
Sealed predictions
- RAG1 in dopamine neurons, braak+0.57 (p 0.108) → +0.29 (p 0.443)receipt 9643
Swarm cases
receipt 9643: RAG1 in dopamine neurons, braak
- power
- full sample +0.49 (p 0.041, n 18), 95% CI +0.02 to +0.78. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.44 (p 0.064, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.44 (p 0.069, n 18). could be the mix.
- skeptic
- leave-one-out range +0.42 to +0.64, sign flips 0; without severely affected donors +0.49 (p 0.041, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RAG1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts